• IGM Biosciences Appoints Chris Takimoto as CMO firstwordpharma
    July 30, 2021
    IGM today announced the appointment of Chris H. Takimoto, M.D., Ph.D., F.A.C.P., to the role of Chief Medical Officer, effective today. Dr. Takimoto will be responsible for global development of IGM's clinical pipeline of proprietary IgM antibodies.
  • National Jewish Health Offers Expanded COVID-19 Antibody Testing prnewswire
    June 11, 2020
    National Jewish Health continues to increase its testing capabilities for COVID-19 antibodies, including the addition of new validated testing equipment.
PharmaSources Customer Service